# KymaThera funding rounds and investors

As of 20 Nov 2026, KymaThera has raised $80M across 1 verified round on record; latest: $80m Series B led by Alta Partners, announced 1 Oct 2026.

A provider of precision medicines for genetically defined diseases

Website: https://kymathera.com  
Headquarters: San Diego, CA  
Page: https://fireround.dev/companies/kymathera

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-10-01 | Series B | $80m | Alta Partners | Foresite Capital, J. Wood Capital, Venrock | [prnewswire.com](https://www.prnewswire.com/news-releases/kymathera-announces-80-million-series-b-financing-to-advance-k-1728-a-next-generation-pan-mutant-selective-pi3k-inhibitor-for-cancer-and-vascular-malformations-302899716.html), [bioworld.com](https://www.bioworld.com/articles/734511-kymathera-grabs-80m-series-b-for-next-gen-pi3k-inhibitor), [bioworld.com](https://www.bioworld.com/articles/734543-kymathera-closes-series-b-financing-to-advance-k-1728) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.
